ILLUMINA, INC.

ILMN
Real-time Estimate Quote. Real-time Estimate  - 09/22 09:10:27 am
268.85USD -0.47%
Prev.295.5000
Open266.8700
High283.2400
Low260.4200
Volume7 343 462
Latest news
16h ago
16h ago
20h ago
22h ago
Chart ILLUMINA, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance315401384
Spread/Res.-14%-33%-30%
Spread/Supp.1,5%8,8%16%
Support266248233
Financials
Sales 2020 3 090 M - -
Net income 2020 528 M - -
Net cash 2020 2 294 M - -
P/E ratio 2020 78,6x
Yield 2020 -
Capitalization 39 536 M 39 536 M -
EV / Sales 2020 12,1x
EV / Sales 2021 9,32x
Nbr of Employees 7 700
Free-Float 75,0%
Company
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations,...

>> Read more
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2020-10-27 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus HOLD
Number of Analysts 17
Average target price 314,44 $
Last Close Price 270,13 $
Spread / Highest target 44,4%
Spread / Average Target 16,4%
Spread / Lowest Target -18,6%